Rights and permissions
About this article
Cite this article
Rituximab confirmed as cost effective for CLL in Romania. Pharmacoecon. Outcomes News 608, 11 (2010). https://doi.org/10.2165/00151234-201006080-00034
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201006080-00034